Autologous GVHD?
An update on allogeneic hematopoietic progenitor cell transplantation for myeloproliferative neoplasms in the era of tyrosine kinase inhibitors
Allogeneic hematopoietic cell transplantation for mycosis fungoides and Sezary syndrome
A phase II study of V-BEAM as conditioning regimen before second auto-SCT for multiple myeloma
Bortezomib improves outcome after SCT in multiple myeloma patients with end-stage renal failure
Hematopoietic SCT for the Black African and non-Black African variants of sickle cell anemia
Sputum cytokine levels in patients undergoing hematopoietic SCT and comparison with healthy subjects and COPD: a pilot study
Incidence and risk factors for moderate-to-severe veno-occlusive disease of the liver after allogeneic stem cell transplantation using a reduced intensity conditioning regimen
Aerobic exercise capacity at long-term follow-up after paediatric allogeneic haematopoietic SCT
BAT2 and BAT3 polymorphisms as novel genetic risk factors for rejection after HLA-related SCT
Sleep quality following hematopoietic stem cell transplantation: longitudinal trajectories and biobehavioral correlates
Salvage therapy with everolimus reduces the severity of treatment-refractory chronic GVHD without impairing disease control: A dual center retrospective analysis
Deferrals of volunteer stem cell donors referred for evaluation for matched-unrelated stem cell donation
Quality of life and outcomes in patients ≥ 60 years of age after allogeneic hematopoietic cell transplantation
Analysis of post-transplant chimerism by using a single amplification reaction of 38 Indel polymorphic loci
Conservative management of pneumatosis intestinalis after allogeneic hematopoietic SCT
Association between mobilization regimen and PFS after auto-SCT for multiple myeloma
A retrospective multi-centre study of the effects of allogeneic haematopoietic SCT on pulmonary function
Improvement of high serum levels of biomarkers of endothelial injury after allogeneic hematopoietic SCT with pre-existing severe hepatitis using recombinant human soluble thrombomodulin
Successful hematopoietic cell transplantation in patients with unique NF-κB essential modulator (NEMO) mutations
Angioedema in patients treated with sirolimus and ACE inhibitor post hematopoietic SCT
Tracheobronchomalacia after allogeneic BMT; pulmonary function test findings similar to those of bronchiolitis obliterans
BAT2 and BAT3 polymorphisms as novel genetic risk factors for rejection after HLA-related SCT